These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18854237)

  • 1. An inhibitor of gram-negative bacterial virulence protein secretion.
    Felise HB; Nguyen HV; Pfuetzner RA; Barry KC; Jackson SR; Blanc MP; Bronstein PA; Kline T; Miller SI
    Cell Host Microbe; 2008 Oct; 4(4):325-36. PubMed ID: 18854237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disarming the invader.
    Young GM
    Chem Biol; 2003 Mar; 10(3):204-5. PubMed ID: 12670533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for the development and use of gram-negative bacterial virulence protein secretion inhibitors for prophylaxis and treatment of infectious diseases.
    Felise HB; Miller SI
    Crit Rev Immunol; 2010; 30(1):69-77. PubMed ID: 20370621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium.
    Kimura K; Iwatsuki M; Nagai T; Matsumoto A; Takahashi Y; Shiomi K; Omura S; Abe A
    J Antibiot (Tokyo); 2011 Feb; 64(2):197-203. PubMed ID: 21139624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting effectors: the molecular recognition of Type III secreted proteins.
    Arnold R; Jehl A; Rattei T
    Microbes Infect; 2010 May; 12(5):346-58. PubMed ID: 20178857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad-spectrum quorum sensing and biofilm inhibition by green tea against gram-negative pathogenic bacteria: Deciphering the role of phytocompounds through molecular modelling.
    Qais FA; Khan MS; Ahmad I
    Microb Pathog; 2019 Jan; 126():379-392. PubMed ID: 30476580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulence factors of gram-negative bacteria in sepsis with a focus on Neisseria meningitidis.
    Livorsi DJ; Stenehjem E; Stephens DS
    Contrib Microbiol; 2011; 17():31-47. PubMed ID: 21659746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antivirulence drugs to target bacterial secretion systems.
    Baron C
    Curr Opin Microbiol; 2010 Feb; 13(1):100-5. PubMed ID: 20079679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria.
    Keyser P; Elofsson M; Rosell S; Wolf-Watz H
    J Intern Med; 2008 Jul; 264(1):17-29. PubMed ID: 18393958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial pathogenesis: the answer to virulence is in the pore.
    Gauthier A; Finlay BB
    Curr Biol; 2001 Apr; 11(7):R264-7. PubMed ID: 11413015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autotransporter and two-partner secretion: delivery of large-size virulence factors by gram-negative bacterial pathogens.
    Newman CL; Stathopoulos C
    Crit Rev Microbiol; 2004; 30(4):275-86. PubMed ID: 15646401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted 2-imino-5-arylidenethiazolidin-4-one inhibitors of bacterial type III secretion.
    Kline T; Felise HB; Barry KC; Jackson SR; Nguyen HV; Miller SI
    J Med Chem; 2008 Nov; 51(22):7065-74. PubMed ID: 18947223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural biology of bacterial secretion systems in gram-negative pathogens--potential for new drug targets.
    Durand E; Verger D; Rêgo AT; Chandran V; Meng G; Fronzes R; Waksman G
    Infect Disord Drug Targets; 2009 Nov; 9(5):518-47. PubMed ID: 19594425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.
    Duncan MC; Linington RG; Auerbuch V
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5433-41. PubMed ID: 22850518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Injectisome, a Complex Nanomachine for Protein Injection into Mammalian Cells.
    Lara-Tejero M; Galán JE
    EcoSal Plus; 2019 Mar; 8(2):. PubMed ID: 30942149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II secretion: a protein secretion system for all seasons.
    Cianciotto NP
    Trends Microbiol; 2005 Dec; 13(12):581-8. PubMed ID: 16216510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VirB8: a conserved type IV secretion system assembly factor and drug target.
    Baron C
    Biochem Cell Biol; 2006 Dec; 84(6):890-9. PubMed ID: 17215876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type III secretion machines: bacterial devices for protein delivery into host cells.
    Galán JE; Collmer A
    Science; 1999 May; 284(5418):1322-8. PubMed ID: 10334981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sortase A: an ideal target for anti-virulence drug development.
    Cascioferro S; Totsika M; Schillaci D
    Microb Pathog; 2014 Dec; 77():105-12. PubMed ID: 25457798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of type III secretion genes as a general indicator of bacterial virulence.
    Stuber K; Frey J; Burnens AP; Kuhnert P
    Mol Cell Probes; 2003 Feb; 17(1):25-32. PubMed ID: 12628591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.